Asia Pacific In-Vitro Diagnostics Market Key Players and Forecast by 2027
Historic Data: 2017-2018 | Base Year: 2019 | Forecast Period: 2020-2027Asia Pacific In-Vitro Diagnostics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product and Services (Reagents and Kits, Instruments, and Software and Services); Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others); Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others); End User (Hospitals, Laboratories, Homecare, and Others)
- Report Date : May 2021
- Report Code : TIPRE00022120
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 217
The In-vitro diagnostics market in Asia Pacific is expected to grow from US$ 13,729.8 million in 2019 to US$ 20,401.5 million by 2027; it is estimated to grow at a CAGR of 5.1% from 2020 to 2027.
The growing healthcare industry in the developing countries in Asia Pacific is creating better opportunities for the major market players to expand their business. Moreover, huge patient population in emerging countries is generating demand for advanced diagnostic systems. For instance, according to the global burden of disease data, India has 18% of the world’s population, but it has 32% of global burden of respiratory diseases. Similarly, according to the new Tulane University study published in 2018, 8.6% of the Chinese population suffers from the chronic lung disease. Additionally, implementation of intense market penetration strategies in the region are anticipated to strengthen the market in the region. For instance, in December 2019, Boditech Med Inc., one of the significant players in the in-vitro diagnostics market entered into Japan market by receiving regulatory approval from Japanese authorities. Thus, growing healthcare sector in the region is likely to boost the market and is anticipated to provide significant growth opportunities to the players operating in the market during the forecast period.
The healthcare industry is growing significantly in this region. The healthcare industry's growth is influenced by the rising number of startups in the in-vitro diagnostics and other healthcare segments. Despite the destruction made by the pandemic, countries have experienced excellent growth opportunities. Countries like India, Japan, and South Korea have emerged as developers of various innovative technologies to detect COVID-19 infection. Various small players have received authorities to manufacture point of care diagnostics and in-vitro diagnostics test systems. In addition, in India, the development of vaccines has attracted various investors to invest in the region's healthcare system and leverage the market's growth in the following years.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the In-vitro diagnostics market. The Asia Pacific In-vitro diagnostics market is expected to grow at a good CAGR during the forecast period.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Asia Pacific In-Vitro Diagnostics Market Segmentation
By Product and Services
- Instruments
- Reagents & Kits
- Software & Services
By Technology
- Immunoassay/ Immunochemistry
- Clinical Chemistry
- Molecular Diagnostics
- Microbiology
- Blood Glucose Self-Monitoring
- Coagulation & Hemostasis
- Hematology
- Urinalysis
- Others
By Application
- Infectious Diseases
- Diabetes
- Oncology
- Cardiology
- Autoimmune Diseases
- Nephrology
- Others
By End User
- Hospitals
- Laboratories
- Homecare
- Others
By Country
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia Pacific
Companies Mentioned
- F. HOFFMANN-LA ROCHE LTD.
- DANAHER
- ABBOTT
- SIEMENS AG
- SYSMEX CORPORATION
- THERMO FISHER SCIENTIFIC, INC.
- BD
- BIOMERIEUX SA
- BIO-RAD LABORATORIES, INC.
- QIAGEN
Asia Pacific In-Vitro Diagnostics Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 13,729.8 Million |
| Market Size by 2027 | US$ 20,401.5 Million |
| Global CAGR (2020 - 2027) | 5.1% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product and Services
|
| Regions and Countries Covered | Asia-Pacific
|
| Market leaders and key company profiles |
Market Research & Consulting
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
Yukihiko Adachi CEO, Deep Blue, LLC.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Strategic Planning
- Investment Justification
- Identifying Emerging Markets
- Enhancing Marketing Strategies
- Boosting Operational Efficiency
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.
- F. HOFFMANN-LA ROCHE LTD.
- DANAHER
- ABBOTT
- SIEMENS AG
- SYSMEX CORPORATION
- THERMO FISHER SCIENTIFIC, INC.
- BD
- BIOMERIEUX SA
- BIO-RAD LABORATORIES, INC.
- QIAGEN
Get Free Sample For